BioNexus Gene Lab (BGLC) Other financing activities (2024)
BioNexus Gene Lab (BGLC) posted Other financing activities of $1064.0 for Q4 2024, down 32.91% sequentially from $1586.0 in Q3 2024.
BioNexus Gene Lab (BGLC) Other financing activities (2024) Analysis & Trends
BioNexus Gene Lab has reported Other financing activities for 1 years, with the latest figure at $1064.0 in Q4 2024.
- Quarterly Other financing activities changed N/A year-over-year to $1064.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2650.0 (changed N/A YoY) and the FY2024 annual result came in at $79851.0, changed N/A from the prior year.
- Other financing activities fell to $1064.0 in Q4 2024 per BGLC's latest filing, from $1586.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1586.0 in Q3 2024 and troughed at $1064.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,064.00 |
| Dec 31, 2024 | 1,064.00 |
| Sep 30, 2024 | 1,586.00 |
| Sep 30, 2024 | 1,586.00 |